Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.
Dushyanthen S, Teo ZL, Caramia F, Savas P, Mintoff CP, Virassamy B, Henderson MA, Luen SJ, Mansour M, Kershaw MH, Trapani JA, Neeson PJ, Salgado R, McArthur GA, Balko JM, Beavis PA, Darcy PK, Loi S.
Dushyanthen S, et al. Among authors: darcy pk.
Nat Commun. 2017 Sep 19;8(1):606. doi: 10.1038/s41467-017-00728-9.
Nat Commun. 2017.
PMID: 28928458
Free PMC article.